Nalu Neurostimulation System
Stimulator, Spinal-Cord, Implanted (Pain Relief). 510(k) K221376, from Boston Scientific Neuromodulation (Valencia, CA). Product code GZB, class 2.
As of Nov 22, 2026, K221376 is an FDA 510(k) held by Boston Scientific Neuromodulation, substantially equivalent on Jun 10, 2022 after 29 days, with no recalls tied to it in FDA's recall database.
- Review time: 29 days
- Recalls: 0
- Cited as a predicate by: 1 device
Spinal Cord Stimulation (SCS) This system is indicated as the sole mitigating agent, or as an adjunct to other modes of therapy used in a multidisciplinary approach for chronic, intractable pain of the trunk and/or limbs, including unilateral or bilateral pain.
- Nalu Neurostimulation SystemK203547 · Boston Scientific Neuromodulation · Mar 25, 2021
- Nalu Neurostimulation SCS systemK201618 · Boston Scientific Neuromodulation · Jul 15, 2020
- Nalu Neurostimulation System for Spinal Cord Stimulation; Nalu Neurostimulation System for Peripheral Nerve StimulationK233801 · Boston Scientific Neuromodulation · Aug 23, 2024
- Nalu Neurostimulation System for Spinal Cord Stimulation; Nalu Neurostimulation System for Peripheral Nerve StimulationK233801 · Boston Scientific Neuromodulation · Aug 23, 2024
- Nalu Neurostimulation SystemK203547 · Boston Scientific Neuromodulation · Mar 25, 2021
- Document
- 510(k) summary (PDF) ↗
- Type
- Special
- Received
- May 12, 2022
- Review panel
- Neurology
- Regulation
- 21 CFR 882.5880
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files